Century Therapeutics (IPSC) PT Lowered to $17 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts IPSC Hot Sheet
Price: $2.07 -4.61%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
H.C. Wainwright analyst Mitchell Kapoor lowered the price target on Century Therapeutics (NASDAQ: IPSC) to $17.00 (from $19.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Suntory Beverage & Food Ltd (2587:JP) (STBFY) PT Lowered to JPY4,600 at Nomura/Instinet
- Otsuka Holdings Co Ltd. (4578:JP) (OTSKY) PT Raised to JPY11,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
